Ameliorative effects of a polyphenolic fraction of Cinnamomum zeylanicum L. bark in animal models of inflammation and arthritis

Scientia Pharmaceutica

Volumn 81, Issue 2, 2013, Pages 567-589

  Rathi, Badal ^a   Bodhankar, Subhash ^a   Mohan, V ^b   Thakurdesai, Prasad ^b  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^b Indus Biotech Private Limited   (India)

Author keywords

Antiinflammatory; Cinnamon bark; Rheumatoid arthritis

Indexed keywords

ACETIC ACID; CARRAGEENAN; CELECOXIB; CINNAMOMUM ZEYLANICUM EXTRACT; CONCANAVALIN A; FREUND ADJUVANT; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; PHENOL; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BARK; CINNAMOMUM ZEYLANICUM; CONTROLLED STUDY; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FOREIGN BODY GRANULOMA; INFLAMMATION; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; PAW EDEMA; POLYARTHRITIS; RAT; RHEUMATOID ARTHRITIS; STOMACH EROSION; STOMACH HEMORRHAGE; WRITHING TEST;

EID: 84879320695     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1301-16     Document Type: Article

References (77)

1. Firestein GS. VIP: a very important protein in arthritis. Nat Med. 2001; 7: 537-538. http://dx.doi.org/10.1038/87859
2. Warrier PK, Ramankutty C, Nambiar VPK, Nair RV. Indian medicinal plants: a compendium of 500 species. Madras: Orient Longman, 1993.
3. Kirtikar KR, Basu B, Blatter E. Indian medicinal plants. Dehra Dun: Bishen Singh Mahendra Pal Singh, 1975.
4. Khory RN, Katrak NN. Materia medica of India and their therapeutics. Delhi: Neeraj Publishing House, 1903; 809 p.
5. Ambasto SP, ed. The useful plants of India. New Delhi: Publications and Information Directorate, Council of Scientific and Industrial Research; 1986.
6. Asolkar LV, Chopra RN, Kakkar KK, Chakre OJ; eds. Second supplement to Glossary of Indian medicinal plants with active principles. Part 1, (A-K) (1965-1981). New Delhi: Publications & Information Directorate, CSIR; 1992.
7. Newall CA, Anderson LA, Phillipson JD. Herbal medicines: a guide for health-care professionals. London: Pharmaceutical Press, 1996.
8. Kubo M, Ma S, Wu J, Matsuda H. Anti-inflammatory activities of 70% methanolic extract from Cinnamomi Cortex. Biol Pharm Bull. 1996; 19: 1041-1045. http://dx.doi.org/10.1248/bpb.19.1041
9. Mitra SK, Sundaram R, Venkataranganna MV, Gopumadhavan S, Prakash NS, Jayaram HD, Sarma DN. Anti-inflammatory, antioxidant and antimicrobial activity of Ophthacare brand, an herbal eye drops. Phytomedicine. 2000; 7: 123-127. http://dx.doi.org/10.1016/S0944-7113(00)80084-7
10. Atta AH, Alkofahi A. Anti-nociceptive and anti-inflammatory effects of some Jordanian medicinal plant extracts. J Ethnopharmacol. 1998; 60: 117-124. http://dx.doi.org/10.1016/S0378-8741(97)00137-2
11. Ravindran PN, Nirmal Babu K, Shylaja M; eds. Cinnamon and cassia: the genus Cinnamomum. Boca Raton: CRC Press; 2004.
12. Chang H-M, But PP-H; eds. Pharmacology and applications of Chinese materia medica. Singapore: World Scientific; 1986.
13. Lee BJ, Kim YJ, Cho DH, Sohn NW, Kang H. Immunomodulatory effect of water extract of cinnamon on anti-CD3-induced cytokine responses and p38, JNK, ERK1/2, and STAT4 activation. Immunopharmacol Immunotoxicol. 2011; 33: 714-722. http://dx.doi.org/10.3109/08923973.2011.564185
14. Tang W, Eisenbrand G. Chinese drugs of plant origin: chemistry, pharmacology, and use in traditional and modern medicine. Berlin: Springer-Verlag, 1992.
15. Cao H, Urban JF, Jr., Anderson RA. Cinnamon polyphenol extract affects immune responses by regulating anti-and proinflammatory and glucose transporter gene expression in mouse macrophages. J Nutr. 2008; 138: 833-840. http://www.ncbi.nlm.nih.gov/pubmed/18424588
16. Lazarus SA, Adamson GE, Hammerstone JF, Schmitz HH. High-performance liquid Chromatography/Mass spectrometry analysis of proanthocyanidins in foods and beverages. J Agric Food Chem. 1999; 47: 3693-3701. http://dx.doi.org/10.1021/jf9813642
17. Garella S, Matarese RA. Renal effects of prostaglandins and clinical adverse effects of nonsteroidal anti-inflammatory agents. Medicine (Baltimore). 1984; 63: 165. http://dx.doi.org/10.1097/00005792-198405000-00003
18. Pennings EJ, Verkes RJ, de Koning J, Bommele JJ, Jansen GS, Vermeij P. Tranylcypromine intoxication with malignant hyperthermia, delirium, and thrombocytopenia. J Clin Psychopharmacol. 1997; 17: 430-432. http://dx.doi.org/10.1097/00004714-199710000-00020
19. Prasit P, Wang Z, Brideau C, Chan CC, Charleson S, Cromlish W, Ethier D, Evans J, Ford-Hutchinson A, Gauthier J. The discovery of rofecoxib,[MK 966, VIOXX®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor. Bioorg Med Chem Lett. 1999; 9: 1773-1778. http://dx.doi.org/10.1016/S0960-894X(99)00288-7
20. Anderson RA, Broadhurst CL, Polansky MM, Schmidt WF, Khan A, Flanagan VP, Schoene NW, Graves DJ. Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J Agric Food Chem. 2004; 52: 65-70. http://dx.doi.org/10.1021/jf034916b
21. Fine AM. Oligomeric proanthocyanidin complexes: history, structure, and phytopharmaceutical applications. Altern Med Rev. 2000; 5: 144-151. http://www.ncbi.nlm.nih.gov/pubmed/10767669
22. Singleton V, Rossi Jr J. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am J Enology Viticult. 1965; 16: 144.
23. Spector WG, Willoughby DA; eds. The pharmacology of inflammation. London: English Universities; 1968.
24. Sharma JN. Involvement of the kinin-forming system in the physiopathology of rheumatoid inflammation. Agents Actions Suppl. 1992; 38 (Pt 3): 343-361. http://www.ncbi.nlm.nih.gov/pubmed/1334358
25. Scott DT, Lam FY, Ferrell WR. Acute joint inflammation--mechanisms and mediators. Gen Pharmacol. 1994; 25: 1285-1296. http://dx.doi.org/10.1016/0306-3623(94)90151-1
26. Tanaka S, Sohen S, Fukuda K. A role for histamine receptors in rheumatoid arthritis. Semin Arthritis Rheum. 1997; 26: 824-833. http://dx.doi.org/10.1016/S0049-0172(97)80026-1
27. Lombardino JG. Nonsteroidal antiinflammatory drugs. New York; Chichester: Wiley, 1985; 442.
28. Tang L, Jennings TA, Eaton JW. Mast cells mediate acute inflammatory responses to implanted biomaterials. Proc Natl Acad Sci U S A. 1998; 95: 8841-8846. http://dx.doi.org/10.1073/pnas.95.15.8841
29. Koganov M, Dueva O, Tsorin B. Activities of plant-derived phenols in a fibroblast cell culture model. J Nat Prod. 1999; 62: 481-483. http://dx.doi.org/10.1021/np9801559
30. Swingle KT. Evaluation of anti-inflammatory activity. In: Scherrer RA, Whitehouse MW; eds. Antiinflammatory agents; chemistry and pharmacology. 34. New York: Academic Press, 1974; 122.
31. Scherrer RA, Whitehouse MW; eds. Antiinflammatory agents: chemistry and pharmacology. New York; London: Academic Press; 1974.
32. Besson JM. The complexity of physiopharmacologic aspects of pain. Drugs. 1997; 53 (Suppl 2): 1-9. http://www.ncbi.nlm.nih.gov/pubmed/9190319
33. Ferreira S, Vane J. New aspects of the mode of action of nonsteroid anti-inflammatory drugs. Annu Rev Pharmacol. 1974; 14: 57-73. http://dx.doi.org/10.1146/annurev.pa.14.040174.000421
34. Van der Wende C, Margolin S; eds. Analgesic tests based upon experimentally induced acute abdominal pain in rats. Fed Proc. 1956; 15: 494.
35. Siegmund E, Cadmus R, Lu G. A method for evaluating both non-narcotic and narcotic analgesics. Proc Soc Exp Biol Med. 1957; 95: 729-731. http://www.ncbi.nlm.nih.gov/pubmed/13465785
36. McMahon S. Are there fundamental differences in the peripheral mechanisms of visceral and somatic pain? Behav Brain Sci. 1997; 20: 381-391. http://dx.doi.org/10.1017/S0140525X97231481
37. Martinez V, Thakur S, Mogil JS, Tache Y, Mayer EA. Differential effects of chemical and mechanical colonic irritation on behavioral pain response to intraperitoneal acetic acid in mice. Pain. 1999; 81: 179-186. http://dx.doi.org/10.1016/S0304-3959(99)00008-1
38. Randall LO, Selitto JJ. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther. 1957; 111: 409-419. http://www.ncbi.nlm.nih.gov/pubmed/13471093
39. Billingham MEJ. Models of arthritis and the search for anti-arthritic drugs. In: Orme M, ed. Anti-rheumatic drugs. New York: Pergamon, 1990; 1-47.
40. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest. 1996; 97: 2672-2679. http://dx.doi.org/10.1172/JCI118717
41. Billingham M. Models of arthritis and the search for anti-arthritic drugs. Pharmacol Ther. 1983; 21: 389-428. http://dx.doi.org/10.1016/0163-7258(83)90062-1
42. He YP, Li ZY, Jiang XD, Feng W, Xu Y, Xiong P. Effects of TNF-alpha receptor blocking peptide on adjuvant arthritis in rats. Yao Xue Xue Bao. 2003; 38: 889-892. http://www.ncbi.nlm.nih.gov/pubmed/15040077
43. Qin B, Dawson H, Polansky MM, Anderson RA. Cinnamon extract attenuates TNF-alpha-induced intestinal lipoprotein ApoB48 overproduction by regulating inflammatory, insulin, and lipoprotein pathways in enterocytes. Horm Metab Res. 2009; 41: 516-522. http://dx.doi.org/10.1055/s-0029-1202813
44. Kanuri G, Weber S, Volynets V, Spruss A, Bischoff SC, Bergheim I. Cinnamon extract protects against acute alcohol-induced liver steatosis in mice. J Nutr. 2009; 139: 482-487. http://dx.doi.org/10.3945/jn.108.100495
45. Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin AS, Jr. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science. 2000; 289: 2363-2366. http://dx.doi.org/10.1126/science.289.5488.2363
46. Panayi G. T-cell-dependent pathways in rheumatoid arthritis. Curr Opin Rheumatol. 1997; 9: 236. http://dx.doi.org/10.1097/00002281-199705000-00010
47. Feldmann M, Maini RN. Discovery of TNF-α as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies. Joint Bone Spine. 2002; 69: 12-8. http://dx.doi.org/10.1016/S1297-319X(01)00335-9
48. Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M, Harriman GR, Maini RN; Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med. 2000; 343: 1594-602. http://dx.doi.org/10.1056/NEJM200011303432202
49. Roubenoff R, Freeman L, Smith D, Abad L, Dinarello C, Kehayias J. Adjuvant arthritis as a model of inflammatory cachexia. Arthritis Rheum. 1997; 40: 534-539. http://dx.doi.org/10.1002/art.1780400320
50. Roubenoff R. Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century. Arthritis Res Ther. 2009; 11: 108. http://dx.doi.org/10.1186/ar2658
51. Walsmith J, Roubenoff R. Cachexia in rheumatoid arthritis. Int J Cardiol. 2002; 85: 89-99. http://www.ncbi.nlm.nih.gov/pubmed/12163213
52. Erhardt A, Biburger M, Papadopoulos T, Tiegs G. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology. 2007; 45: 475-485. http://dx.doi.org/10.1002/hep.21498
53. Cantrell DA, Smith KA. The interleukin-2 T-cell system: a new cell growth model. Science. 1984; 224: 1312-1316. http://dx.doi.org/10.1126/science.6427923
54. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995; 155: 1151-1164. http://www.ncbi.nlm.nih.gov/pubmed/7636184
55. Watanabe Y, Lee S, Allison AC. Control of the expression of a class II major histocompatibility gene (HLA-DR) in various human cell types: down-regulation by IL-1 but not by IL-6, prostaglandin E2, or glucocorticoids. Scand J Immunol. 1990; 32: 601-609. http://dx.doi.org/10.1111/j.1365-3083.1990.tb03202.x
56. Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci U S A. 1994; 91: 8562-8566. http://dx.doi.org/10.1073/pnas.91.18.8562
57. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol. 1994; 12: 227-57. http://dx.doi.org/10.1146/annurev.iy.12.040194.001303
58. Nicholson LB, Kuchroo VK. Manipulation of the Th1/Th2 balance in autoimmune disease. Curr Opin Immunol. 1996; 8: 837-842. http://dx.doi.org/10.1016/S0952-7915(96)80013-6
59. DeGre M, Mellbye OJ, Clarke-Jenssen O. Immune interferon in serum and synovial fluid in rheumatoid arthritis and related disorders. Ann Rheum Dis. 1983; 42: 672-676. http://dx.doi.org/10.1136/ard.42.6.672
60. Tabak M, Armon R, Neeman I. Cinnamon extracts' inhibitory effect on Helicobacter pylori. J Ethnopharmacol. 1999; 67: 269-277. http://dx.doi.org/10.1016/S0378-8741(99)00054-9
61. Nir Y, Potasman I, Stermer E, Tabak M, Neeman I. Controlled trial of the effect of cinnamon extract on Helicobacter pylori. Helicobacter. 2000; 5: 94-97. http://dx.doi.org/10.1046/j.1523-5378.2000.00014.x
62. Hasani-Ranjbar S, Larijani B, Abdollahi M. A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases. Inflamm Allergy Drug Targets. 2009; 8: 2-10. http://dx.doi.org/10.2174/187152809787582561
63. Dhuley JN. Anti-oxidant effects of cinnamon (Cinnamomum verum) bark and greater cardamom (Amomum subulatum) seeds in rats fed high fat diet. Indian J Exp Biol. 1999; 37: 238-242. http://www.ncbi.nlm.nih.gov/pubmed/10641152
64. Lee JS, Jeon SM, Park EM, Huh TL, Kwon OS, Lee MK, Choi MS. Cinnamate supplementation enhances hepatic lipid metabolism and antioxidant defense systems in high cholesterol-fed rats. J Med Food. 2003; 6: 183-191. http://dx.doi.org/10.1089/10966200360716599
65. Lin CC, Wu SJ, Chang CH, Ng LT. Antioxidant activity of Cinnamomum cassia. Phytother Res. 2003; 17: 726-730. http://dx.doi.org/10.1002/ptr.1190
66. Panickar KS, Polansky MM, Anderson RA. Cinnamon polyphenols attenuate cell swelling and mitochondrial dysfunction following oxygen-glucose deprivation in glial cells. Exp Neurol. 2009; 216: 420-427. http://dx.doi.org/10.1016/j.expneurol.2008.12.024
67. Winter CA, Risley EA, Nuss WG. Carrageenin-induced edema in hind paw of the rats as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med. 1962; 111: 544-547. http://www.ncbi.nlm.nih.gov/pubmed/14001233
68. Roy DK, Kumar KT, Karmakar S, Pal S, Samanta SK, Adhikari D, Sen T. Pharmacological studies on Indian black tea (leaf variety) in acute and chronic inflammatory conditions. Phytother Res. 2008; 22: 814-819. http://dx.doi.org/10.1002/ptr.2375
69. Nargund LV, Hariprasad V, Reedy GR. Synthesis and anti-inflammatory activity of fluorinated phenyl styryl ketones and N-phenyl-5-substituted aryl-3-p-(fluorophenyl) pyrazolins and pyrazoles. J Pharm Sci. 1992; 81: 892-894. http://dx.doi.org/10.1002/jps.2600810910
70. Swingle KF, Shideman FE. Phases of the inflammatory response to subcutaneous implantation of a cotton pellet and their modification by certain anti-inflammatory agents. J Pharmacol Exp Ther. 1972; 183: 226-234. http://www.ncbi.nlm.nih.gov/pubmed/4562620
71. Collier HO, Dinneen LC, Johnson CA, Schneider C. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol. 1968; 32: 295-310. http://www.ncbi.nlm.nih.gov/pubmed/4230818
72. Ward JR, Cloud RS. Comparative effect of antirheumatic drugs on adjuvant-induced polyarthritis in rats. J Pharmacol Exp Ther. 1966; 152: 116-121. http://www.ncbi.nlm.nih.gov/pubmed/5937395
73. Koufany M, Moulin D, Bianchi A, Muresan M, Sebillaud S, Netter P, Weryha G, Jouzeau JY. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis. Arthritis Res Ther. 2008; 10: R6. http://dx.doi.org/10.1186/ar2354
74. Hua J, Suguro S, Hirano S, Sakamoto K, Nagaoka I. Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats. Inflamm Res. 2005; 54: 127-132. http://dx.doi.org/10.1007/s00011-004-1333-6
75. Balkan A, Goren Z, Urgun H, Calis U, Cakar AN, Atilla P, Uzbay T. Evaluation of the analgesic and anti-inflammatory activities of some thiazolo[4,5-d]pyrimidines. Arzneimittelforschung. 2002; 52: 462-467. http://dx.doi.org/10.1055/s-0031-1299915
76. Conway JG, Andrews RC, Beaudet B, Bickett DM, Boncek V, Brodie TA, Clark RL, Crumrine RC, Leenitzer MA, McDougald DL, Han B, Hedeen K, Lin P, Milla M, Moss M, Pink H, Rabinowitz MH, Tippin T, Scates PW, Selph J, Stimpson SA, Warner J, Becherer JD. Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases. J Pharmacol Exp Ther. 2001; 298: 900-908. http://www.ncbi.nlm.nih.gov/pubmed/11504783
77. Pandey R, Shankar BS, Sharma D, Sainis KB. Low dose radiation induced immunomodulation: effect on macrophages and CD8+ T cells. Int J Radiat Biol. 2005; 81: 801-812. http://dx.doi.org/10.1080/09553000500531886